Zhao HG, Li HH, Bach G, Schmidtchen A, Neufeld EF. The molecular basis of Sanfilippo syndrome type B. Proc Natl Acad Sci USA 1996;93:6101–5.Google Scholar
Hara A, Kitazawa N, Taketomi T. Abnormalities of glycosphingolipids in mucopolysaccharidosis type III B. J Lipid Res 1984;25:175–84.Google Scholar
Haust MD, Gordon BA. Ultrastructural and biochemical aspects of the Sanfilippo syndrome – type III genetic mucopolysaccharidosis. Connect Tissue Res 1986;15:57–64.Google Scholar
Murata R, Nakajima S, Tanaka A, Miyagi N, Matsuoka O, et al. MR imaging of the brain in patients with mucopolysaccharidosis. AJNR Am J Neuroradiol 1989;10:1165–70.Google Scholar
Valstar MJ, Ruijter GJ, van Diggelen OP, Poorthuis BJ, Wijburg FA. Sanfilippo syndrome: a mini-review. J Inherit Metab Dis 2008;31:240–52.Google Scholar
Cooper DN, Chen JM, Ball EV, Howells K, Mort M, et al. Genes, mutations, and human inherited disease at the dawn of the age of personalized genomics. Hum Mutat 2010;31:631–55.Google Scholar
Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 2010;26:589–95.Google Scholar
Koboldt DC, Chen K, Wylie T, Larson DE, McLellan MD, et al. VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 2009;25:2283–5.Google Scholar
DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 2011;43:491–8.Google Scholar
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010;20:1297–303.Google Scholar
Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010;38:e164.Google Scholar
von Figura K, Lögering M, Kresse H. Serum alpha-N-acetylglucosaminidase: determination, characterization, and corrective activity in Sanifilippo B fibroblasts. Z Klin Chem Klin Biochem 1975;13:285–9.Google Scholar
Zhao HG, Aronovich EL, Whitley CB. Genotype-phenotype correspondence in Sanfilippo syndrome type B. Am J Hum Genet 1998;62:53–63.Google Scholar
Valstar MJ, Bruggenwirth HT, Olmer R, Wevers RA, Verheijen FW, et al. Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype. J Inherit Metab Dis 2010;33:759–67.Google Scholar
Heldermon CD, Ohlemiller KK, Herzog ED, Vogler C, Qin E, et al. Therapeutic efficacy of bone marrow transplant, intracranial AAV-mediated gene therapy, or both in the mouse model of MPS IIIB. Mol Ther 2010;18:873–80.Google Scholar
Fu H, Samulski RJ, McCown TJ, Picornell YJ, Fletcher D, et al. Neurological correction of lysosomal storage in a mucopolysaccharidosis IIIB mouse model by adeno-associated virus-mediated gene delivery. Mol Ther 2002;5:42–9.Google Scholar
Calvo SE, Compton AG, Hershman SG, Lim SC, Lieber DS, et al. Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Sci Transl Med 2012;4:118ra10.Google Scholar
Dixon-Salazar TJ, Silhavy JL, Udpa N, Schroth J, Bielas S, et al. Exome sequencing can improve diagnosis and alter patient management. Sci Transl Med 2012;4:138ra78.Google Scholar
Need AC, Shashi V, Hitomi Y, Schoch K, Shianna KV, et al. Clinical application of exome sequencing in undiagnosed genetic conditions. J Med Genet 2012;49:353–61.Google Scholar
About the article
Published Online: 2017-03-17
Published in Print: 2017-04-01
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: This study was supported by the “National Key Technology R&D Program” (2012BAI09B04, to GXF); the Special Basic Work of Science and Technology (2014FY110700 for GXF); the “Innovation Fund for Translational Medicine Plan” from the Shanghai Jiao Tong University School of Medicine (No. 15ZH3003, to YYG); and grant from the National Natural Science Foundation of China (No. 44107690, to ZQW; 81670812, to YYG).
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.